$2.56
-0.05[-1.92%]
At close: Apr 15
$2.56
0[0.00%]
PreMarket: 7:00AM EDT
Cellectis
(NASDAQ:CLLS)Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 38.825K |
| Day Range | - - - |
| 52 Wk Range | 0.963 - 3.774 |
| Market Cap | $184.201M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 1.5% |
| Days to Cover | 28.02 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cellectis
Sector
Health Care
Industry
Biotechnology
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The compan...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and Adicet Bio (NASDAQ:ACET).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Wednesday, November 1, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 129.89% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.61 last updated April 15, 2024 at 3:59 PM EDT.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.